Jill Buck's most recent trade in Alaunos Therapeutics Inc was a trade of 236,250 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 4, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Jill Buck | EVP, GM Gene Therapy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 236,250 | 236,250 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Jill Buck | EVP, GM Gene Therapy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 31,500 | 231,016 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | Jill Buck | EVP, GM Gene Therapy | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 08 Jan 2021 | 27,894 | 199,516 (0%) | 0% | 3.1 | 87,029 | Common Stock |